S&P Global Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that S&P Global Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.59B | Feb 9, 2018 |
| FY2017 | Sep 30, 2017 | $1.51B | Feb 9, 2018 |
| FY2017 | Jun 30, 2017 | $1.51B | Feb 9, 2018 |
| FY2017 | Mar 31, 2017 | $1.45B | Feb 9, 2018 |
| FY2016 | Dec 31, 2016 | $1.40B | Feb 9, 2017 |
| FY2016 | Sep 30, 2016 | $1.44B | Feb 9, 2017 |
| FY2016 | Jun 30, 2016 | $1.48B | Feb 9, 2017 |
| FY2016 | Mar 31, 2016 | $1.34B | Feb 9, 2017 |
| FY2015 | Dec 31, 2015 | $1.37B | Feb 12, 2016 |
| FY2015 | Sep 30, 2015 | $1.32B | Feb 12, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.34B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $14.21B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $12.50B | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | $11.18B | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | $8.30B | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | $1.87B | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | $1.85B | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | $1.94B | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | $1.79B | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $1.74B | Feb 9, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.47B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.85B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.63B | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | $3.25B | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | $3.02B | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | $454.00M | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | $455.00M | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | $792.00M | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | $639.00M | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $541.00M | Feb 9, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.48B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $5.58B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $4.02B | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | $4.94B | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | $4.22B | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | $656.00M | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | $944.00M | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | $1.11B | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | $912.00M | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $818.00M | Feb 9, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.42B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.20B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.16B | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | $3.40B | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | $1.73B | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $1.54B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $1.34B | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $1.42B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $1.61B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $1.47B | Feb 13, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.65B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $5.69B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.71B | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | $2.60B | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | $3.60B | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $3.57B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $2.78B | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $2.06B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $2.02B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $1.56B | Feb 13, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2009 | Dec 31, 2009 | $68.53M | Feb 24, 2010 |
| FY2009 | Dec 31, 2008 | $105.98M | Feb 24, 2010 |
| FY2009 | Dec 31, 2007 | $229.61M | Feb 24, 2010 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.20B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $60.22B | Feb 11, 2026 |
| FY2023 | Dec 31, 2023 | $60.59B | Feb 9, 2024 |
| FY2023 | Dec 31, 2022 | $61.78B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $15.03B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $12.54B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $11.35B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $9.44B | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $9.43B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $8.67B | Feb 9, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.05B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $22.71B | Feb 11, 2026 |
| FY2023 | Dec 31, 2023 | $22.49B | Feb 9, 2024 |
| FY2023 | Dec 31, 2022 | $22.04B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $9.49B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $9.19B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $8.54B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $7.14B | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $7.31B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $6.89B | Feb 9, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.13B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $33.16B | Feb 11, 2026 |
| FY2023 | Dec 31, 2023 | $34.20B | Feb 9, 2024 |
| FY2023 | Dec 31, 2022 | $36.39B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $2.03B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $509.00M | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $479.00M | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $628.00M | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $709.00M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $650.00M | Feb 9, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.48B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $34.92B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $34.85B | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | $34.55B | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | $3.51B | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $3.74B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $3.58B | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $3.54B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $2.99B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $2.95B | Feb 13, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.67B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $20.98B | Feb 11, 2026 |
| FY2023 | Dec 31, 2023 | $18.73B | Feb 9, 2024 |
| FY2023 | Dec 31, 2022 | $17.78B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $15.02B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $13.37B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $12.21B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $11.28B | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $10.02B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $9.21B | Feb 9, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.75B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.67B | Feb 11, 2026 |
| FY2023 | Dec 31, 2023 | $1.29B | Feb 9, 2024 |
| FY2023 | Dec 31, 2022 | $1.29B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $6.50B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $4.11B | Feb 8, 2022 |
| FY2020 | Dec 31, 2019 | $2.87B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $1.92B | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.78B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $2.39B | Feb 9, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.09B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $11.40B | Feb 11, 2026 |
| FY2023 | Dec 31, 2023 | $11.46B | Feb 9, 2024 |
| FY2023 | Dec 31, 2022 | $10.96B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $4.11B | Feb 10, 2023 |
| FY2011 | Dec 31, 2011 | $1.20B | Feb 7, 2012 |
| FY2011 | Dec 31, 2010 | $1.20B | Feb 7, 2012 |
| FY2010 | Dec 31, 2009 | $1.20B | Feb 23, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 12 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | 10 | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | 12 | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 9, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 12 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | 10 | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | 12 | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 9, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 298.80M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 307.80M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 314.10M | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | 321.90M | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | 241.00M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | 240.60M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | 244.00M | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | 248.40M | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | 253.70M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | 258.30M | Feb 13, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.13B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.15B | Feb 11, 2026 |
| FY2023 | Dec 31, 2022 | $1.02B | Feb 9, 2024 |
| FY2023 | Dec 31, 2021 | $743.00M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $645.00M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $560.00M | Feb 8, 2022 |
| FY2020 | Dec 31, 2018 | $503.00M | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $421.00M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $380.00M | Feb 13, 2019 |